CA2566213A1 - Substantially pure 2-{[2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carbonyl]-amino}-3-(phenylpyridin-2-yl-amino)-propionic acid as an ikb kinase inhibitor - Google Patents
Substantially pure 2-{[2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carbonyl]-amino}-3-(phenylpyridin-2-yl-amino)-propionic acid as an ikb kinase inhibitor Download PDFInfo
- Publication number
- CA2566213A1 CA2566213A1 CA002566213A CA2566213A CA2566213A1 CA 2566213 A1 CA2566213 A1 CA 2566213A1 CA 002566213 A CA002566213 A CA 002566213A CA 2566213 A CA2566213 A CA 2566213A CA 2566213 A1 CA2566213 A1 CA 2566213A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- ikk
- administering
- effective amount
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- AIDS & HIV (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57014604P | 2004-05-12 | 2004-05-12 | |
US60/570,146 | 2004-05-12 | ||
PCT/US2005/016381 WO2005113544A1 (en) | 2004-05-12 | 2005-05-11 | Substantially pure 2-{[2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carbonyl]-amino}-3-(phenylpyridin-2-yl-amino)-propionic acid as an ikb kinase inhibitor |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2566213A1 true CA2566213A1 (en) | 2005-12-11 |
Family
ID=34969825
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002566213A Abandoned CA2566213A1 (en) | 2004-05-12 | 2005-05-11 | Substantially pure 2-{[2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carbonyl]-amino}-3-(phenylpyridin-2-yl-amino)-propionic acid as an ikb kinase inhibitor |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP1747215A1 (pt) |
JP (1) | JP2007537266A (pt) |
KR (1) | KR20070011483A (pt) |
CN (1) | CN1950359A (pt) |
AR (1) | AR049274A1 (pt) |
AU (1) | AU2005245834A1 (pt) |
BR (1) | BRPI0511029A (pt) |
CA (1) | CA2566213A1 (pt) |
EC (1) | ECSP066992A (pt) |
GT (1) | GT200500111A (pt) |
IL (1) | IL178992A0 (pt) |
MA (1) | MA28553B1 (pt) |
MX (1) | MXPA06012870A (pt) |
NO (1) | NO20065719L (pt) |
PA (1) | PA8633101A1 (pt) |
PE (1) | PE20060269A1 (pt) |
RU (1) | RU2006143758A (pt) |
SV (1) | SV2006002111A (pt) |
TN (1) | TNSN06338A1 (pt) |
TW (1) | TW200605881A (pt) |
UY (1) | UY28897A1 (pt) |
WO (1) | WO2005113544A1 (pt) |
ZA (1) | ZA200608712B (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19951360A1 (de) | 1999-10-26 | 2001-05-03 | Aventis Pharma Gmbh | Substituierte Indole |
DE102004033406A1 (de) * | 2004-07-10 | 2006-02-16 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Herstellung der enantiomeren Formen von 2,3-Diaminopropionsäurederivaten |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
US11969501B2 (en) | 2008-04-21 | 2024-04-30 | Dompé Farmaceutici S.P.A. | Auris formulations for treating otic diseases and conditions |
US9132087B2 (en) | 2008-04-21 | 2015-09-15 | Otonomy, Inc. | Auris formulations for treating otic diseases and conditions |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
AU2010351938B2 (en) | 2010-04-27 | 2014-10-30 | Hutchison Medipharma Limited | Pyrimidinyl indole compounds |
US8933024B2 (en) | 2010-06-18 | 2015-01-13 | Sanofi | Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
EP2683699B1 (de) | 2011-03-08 | 2015-06-24 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US8901114B2 (en) | 2011-03-08 | 2014-12-02 | Sanofi | Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof |
US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
EP2683704B1 (de) | 2011-03-08 | 2014-12-17 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
CA3029281A1 (en) | 2016-06-29 | 2018-01-04 | Otonomy, Inc. | Triglyceride otic formulations and uses thereof |
CN106588803A (zh) * | 2016-11-16 | 2017-04-26 | 西南科技大学 | 一种制备5‑乙酰基异噁唑的新方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10237722A1 (de) * | 2002-08-17 | 2004-08-19 | Aventis Pharma Deutschland Gmbh | Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase |
-
2005
- 2005-05-11 JP JP2007513292A patent/JP2007537266A/ja not_active Abandoned
- 2005-05-11 AU AU2005245834A patent/AU2005245834A1/en not_active Abandoned
- 2005-05-11 KR KR1020067023661A patent/KR20070011483A/ko not_active Application Discontinuation
- 2005-05-11 BR BRPI0511029-7A patent/BRPI0511029A/pt not_active IP Right Cessation
- 2005-05-11 CN CNA200580015046XA patent/CN1950359A/zh active Pending
- 2005-05-11 CA CA002566213A patent/CA2566213A1/en not_active Abandoned
- 2005-05-11 GT GT200500111A patent/GT200500111A/es unknown
- 2005-05-11 WO PCT/US2005/016381 patent/WO2005113544A1/en active Application Filing
- 2005-05-11 RU RU2006143758/04A patent/RU2006143758A/ru not_active Application Discontinuation
- 2005-05-11 MX MXPA06012870A patent/MXPA06012870A/es not_active Application Discontinuation
- 2005-05-11 PE PE2005000524A patent/PE20060269A1/es not_active Application Discontinuation
- 2005-05-11 EP EP05749733A patent/EP1747215A1/en not_active Withdrawn
- 2005-05-11 AR ARP050101914A patent/AR049274A1/es not_active Application Discontinuation
- 2005-05-12 PA PA20058633101A patent/PA8633101A1/es unknown
- 2005-05-12 UY UY28897A patent/UY28897A1/es unknown
- 2005-05-12 SV SV2005002111A patent/SV2006002111A/es not_active Application Discontinuation
- 2005-05-12 TW TW094115316A patent/TW200605881A/zh unknown
-
2006
- 2006-10-18 TN TNP2006000338A patent/TNSN06338A1/en unknown
- 2006-10-18 ZA ZA200608712A patent/ZA200608712B/en unknown
- 2006-10-27 MA MA29415A patent/MA28553B1/fr unknown
- 2006-11-01 IL IL178992A patent/IL178992A0/en unknown
- 2006-11-10 EC EC2006006992A patent/ECSP066992A/es unknown
- 2006-12-12 NO NO20065719A patent/NO20065719L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PA8633101A1 (es) | 2006-01-23 |
SV2006002111A (es) | 2006-01-30 |
RU2006143758A (ru) | 2008-06-27 |
JP2007537266A (ja) | 2007-12-20 |
GT200500111A (es) | 2006-05-09 |
CN1950359A (zh) | 2007-04-18 |
BRPI0511029A (pt) | 2007-11-27 |
PE20060269A1 (es) | 2006-05-11 |
AU2005245834A1 (en) | 2005-12-01 |
TW200605881A (en) | 2006-02-16 |
IL178992A0 (en) | 2007-03-08 |
MXPA06012870A (es) | 2007-02-15 |
NO20065719L (no) | 2006-12-12 |
AR049274A1 (es) | 2006-07-12 |
WO2005113544A1 (en) | 2005-12-01 |
KR20070011483A (ko) | 2007-01-24 |
TNSN06338A1 (en) | 2008-02-22 |
UY28897A1 (es) | 2005-12-30 |
ECSP066992A (es) | 2006-12-29 |
ZA200608712B (en) | 2008-06-25 |
EP1747215A1 (en) | 2007-01-31 |
MA28553B1 (fr) | 2007-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2566213A1 (en) | Substantially pure 2-{[2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carbonyl]-amino}-3-(phenylpyridin-2-yl-amino)-propionic acid as an ikb kinase inhibitor | |
EP3134410B1 (en) | Inhibiting the transient receptor potential a1 ion channel | |
US20140309221A1 (en) | Method of inhibiting hamartoma tumor cells | |
HU211968A9 (en) | Heterocyclic amines useful in the therapy of asthma and inflammation of the respiratory tract | |
ES2525756T3 (es) | Imidazo [1,2-a] piridinas como moduladores de JNK | |
EA014918B1 (ru) | Замещенные бициклические пиримидоновые производные | |
KR20230070207A (ko) | 항바이러스제로서 작용화된 펩티드 | |
RU2661895C2 (ru) | Соединение сложного эфира гуанидинобензойной кислоты | |
EP3212652B1 (en) | Ripk2 inhibitors and method of treating cancer with same | |
CA3118381A1 (en) | 6,7-dihydro-4h-pyrazolo[1,5-a]pyrazine indole-2-carboxamides active against the hepatitis b virus (hbv) | |
WO2021193756A1 (ja) | 新規ベンズイミダゾール誘導体 | |
WO2010057877A1 (en) | 7-pyridinyl- or phenyl- substituted triazolo [1, 5 -a] pyridines as pi3k inhibitors | |
AU2021350916A1 (en) | Alpha protein kinase 1 inhibitors and methods of use | |
US20070142417A1 (en) | Substantially Pure 2-{[2-(2-Methylamino-Pyrimidin-4-YL)-1H-Indole-5-Carbonyl]-Amino}-3-Phenylpyridin-2-YL-Amino)-Propionic Acid as an IkB Kinase Inhibitor | |
JP6441830B2 (ja) | カテプシンcの置換2−アザ−ビシクロ[2.2.1]ヘプタン−3−カルボン酸(シアノ−メチル)−アミド阻害剤 | |
EP3544965A1 (en) | Sulfoximine, sulfonimidamide, sulfondiimine and diimidosulfonamide compounds as inhibitors of indoleamine 2, 3-dioxygenase | |
KR20190025545A (ko) | 특정 단백질 키나제 억제제 | |
CA3198096A1 (en) | Aryl derivatives for treating trpm3 mediated disorders | |
CN115003381A (zh) | 化合物及其用于治疗α1-抗胰蛋白酶缺乏症的用途 | |
ES2427968T3 (es) | Nuevos derivados de indol que tienen un grupo carbamoilo, un grupo ureido y un grupo oxi sustituido | |
ES2383340T3 (es) | Derivados de (fenil)-amida del ácido 7-(piperazin-1-ilmetil)-1H-indol-2-carboxílico y compuestos relacionados en calidad de inhibidores de MAP-QUINASA P38 para el tratamiento de enfermedades de las vías respiratorias. | |
CN114621206B (zh) | 一种5-取代的嘧啶二胺类衍生物及其制备方法与应用 | |
CN117337290A (zh) | 三并环类泛素特异性蛋白酶1抑制剂及其用途 | |
KR20120135716A (ko) | 이중대칭 구조의 퀴나졸린 유도체 화합물 및 이의 용도 | |
JP2009539905A (ja) | レニンの活性に依存する疾患に有用なピロリジン誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |